Haerun Nisa Siregar, . (2020) ANALISIS EFEKTIVITAS BIAYA PENGGUNAAN ANTIBIOTIK SEFTRIAKSON DAN SEFOTAKSIM PADA PASIEN PNEUMONIA KOMUNITAS BAYI DAN BALITA DI INSTALASI RAWAT INAP RUMAH SAKIT UMUM PUSAT FATMAWATI TAHUN 2017-2018. Skripsi thesis, Universitas Pembangunan Nasional Veteran Jakarta.
![[img]](http://repository.upnvj.ac.id/style/images/fileicons/text.png) |
Text
ABSTRAK.pdf Download (426kB) |
|
Text
AWAL.pdf Download (586kB) |
|
Text
BAB I.pdf Download (707kB) |
|
Text
BAB II.pdf Restricted to Repository UPNVJ Only Download (1MB) |
|
Text
BAB III.pdf Restricted to Repository UPNVJ Only Download (525kB) |
|
Text
BAB IV.pdf Restricted to Repository UPNVJ Only Download (600kB) |
|
Text
BAB V.pdf Download (360kB) |
|
Text
DAFTAR PUSTAKA.pdf Download (654kB) |
|
Text
RIWAYAT HIDUP.pdf Restricted to Repository UPNVJ Only Download (476kB) |
|
Text
LAMPIRAN.pdf Restricted to Repository UPNVJ Only Download (1MB) |
|
Text
JURNAL.pdf Restricted to Repository staff only Download (510kB) |
Abstract
Pneumonia is an infection of lung tissue which is the leading cause of death in infants and toddlers worldwide. The prevalence of pneumonia in infants and toddlers in Indonesia is very high and is the second-leading cause of mortality with deaths in infants (23.8%) and toddlers (15.5%). Antibiotics are causative therapy for pneumonia. The variety of alternative antibiotic therapies for pneumonia makes pharmacoeconomic studies indispensable to obtain effective therapies at a cost-effective basis. This study aims to determine the costeffectiveness of ceftriaxone and cefotaxime antibiotics in pneumonia patients in infants and toddlers in the Inpatient Installation of Fatmawati General Hospital in 2017-2018. The type of research is observational analytic, cross sectional data collection with a total sample of 70 patients, 35 patients with ceftriaxone therapy and 35 patients with cefotaxime therapy. Sampling is done by simple random technique. The data used in the form of demographic data, length of stay and direct medical costs. Components of direct medical costs of this study include the costs of antibiotics and diagnostic support costs in the form of laboratory examination costs. This research was carried out using the CEA (CostEffectiveness Analysis) method and the cost effectiveness stated in ACER (Averge Cost-Effectiveness Ratio), obtained from the average of total direct medical costs divided by clinical outcome (percentage of effectiveness of therapy). The result showed that the ACER values of ceftriaxone and cefotaxime were Rp 111,295.06 and Rp 88,926.39 respectively. These values indicated that the cefotaxime therapy group is more cost-effective compared to ceftriaxone. Cefotaxime, which is more cost-effective compared to ceftriaxone, is due to higher percentage of effectiveness and shorter period of hospitalization, as the longer the period of treatment will cause either direct or indirect effect on medical costs (William, 2016)
| Item Type: | Thesis (Skripsi) |
|---|---|
| Additional Information: | [No. Panggil : 1610211054] [Pembimbing : Imam Prabowo] [Penguji : Yanti Harjono Hadiwiardjo] |
| Uncontrolled Keywords: | ACER , CEA, Community-Acquired Pneumonia for Infants and Toddlers, Ceftriaxone, Cefotaxime |
| Subjects: | R Medicine > R Medicine (General) R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine |
| Divisions: | Fakultas Kedokteran > Program Studi Kedokteran (S1) |
| Depositing User: | Muamar Khadafi |
| Date Deposited: | 29 Jun 2022 04:22 |
| Last Modified: | 29 Jun 2022 04:22 |
| URI: | http://repository.upnvj.ac.id/id/eprint/18144 |
Actions (login required)
 |
View Item |